LCD and Policy Article Revisions Summary for July 7, 2016

Outlined below are the principal changes to a DME MAC Local Coverage Determination (LCD) and a Policy Article (PA) that have been revised and posted. The policy included is Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics). Please review the entire LCD and related PA for complete information.

Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics)
LCD
Revision Effective Date: 07/01/2016

HCPCS CODES:
Added: HCPCS code Q9981
DOCUMENTATION REQUIREMENTS:
Revised: Standard Documentation language to add New order requirements, and Correct coding instructions; revised Proof of delivery instructions (Effective 04/28/16)
POLICY SPECIFIC DOCUMENTATION REQUIREMENTS:
Added: HCPCS Q9981 for billing instructions

Policy Article
Revision Effective Date: 07/01/2016

NON-MEDICAL NECESSITY COVERAGE AND PAYMENT RULES:
Revised: Covered 3-drug combination regimen with Q9981
CODING GUIDELINES:
Added: HCPCS Q9981 for billing Rolapitant effective on or after 07/01/2016
Added: End date for HCPCS Q0181
Added: HCPCS Q9981 to coding instructions

Note: The information contained in this article is only a summary of revisions to the LCD and Policy Article. For complete information on any topic, suppliers must review the LCD and/or Policy Article.

Last Updated Thu, 04 Aug 2016 11:24:52 +0000